prostate cancer Archive — Page 2 of 9
-
April 3, 2023
More U.S. prostate cancer patients choosing active surveillance
A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers. -
March 16, 2023
Study evaluates polygenic risk score for prostate cancer risk prediction
A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening. -
October 27, 2022
Study reveals pathways for aggressive prostate cancer subtype
Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer. -
August 4, 2022
Clinic helps patients prepare to move beyond prostate cancer
Vanderbilt's REACH for Survivorship Clinic takes a holistic approach to help treat prostate cancer patients. -
December 9, 2021
Prostate cancer treatment regret
Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity. -
October 19, 2021
Combo therapy slows prostate cancer
A new combination treatment showed promise in slowing the growth of castration-resistant prostate cancer in animal models, Vanderbilt researchers discovered. -
September 30, 2021
Prevention Progress